Dialysis Clinical Trials

197 recruitingLast updated: June 18, 2026

There are 197 actively recruiting dialysis clinical trials across 51 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1. Top locations include Shanghai, Shanghai Municipality, China, London, Ontario, Canada, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Dialysis Trials at a Glance

197 actively recruiting trials for dialysis are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 96 trials, with the heaviest enrollment activity in Shanghai, London, and Beijing. Lead sponsors running dialysis studies include London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Cairo University, and First Affiliated Hospital of Wannan Medical College.

Browse dialysis trials by phase

Treatments under study

About Dialysis Clinical Trials

Looking for clinical trials for Dialysis? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dialysis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 197 trials

Recruiting
Not Applicable

Pivotal Study of the Velocity™ pAVF System

Chronic Kidney DiseaseEnd Stage Renal Disease (ESRD)Hemodialysis Access+1 more
Venova Medical126 enrolled12 locationsNCT07153939
Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting

Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)

Chronic Kidney Disease on Hemodialysis
Cardenal Herrera University50 enrolled1 locationNCT07642778
Recruiting
Not Applicable

Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial

End Stage Kidney Disease (ESRD)HemodialysisPerioperative Management
Stanford University30 enrolled1 locationNCT07339202
Recruiting
Phase 2

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

End Stage Renal Disease on DialysisHyperphosphatemiaChronic Kidney Disease Requiring Chronic Dialysis
R1 Therapeutics168 enrolled26 locationsNCT06712654
Recruiting
Phase 3

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia Patients on Peritoneal Dialysis
Taisho Pharmaceutical Co., Ltd.30 enrolled1 locationNCT07548853
Recruiting
Not Applicable

Mindfulness Meditation in Hemodialysis Patients

Sleep QualityStressHemodialysis+1 more
Cyprus Aydin University50 enrolled4 locationsNCT07620990
Recruiting
Not Applicable

Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients

HemodialysisGut MicrobiotaUremic Toxins+2 more
Tungs' Taichung Metroharbour Hospital30 enrolled1 locationNCT07461233
Recruiting
Not Applicable

CanSOLVE 2.0 Theme 3.1 Mind the Gap - Dialectical Behavioural Therapy (DBT) Skills Training Program Pilot

HemodialysisMental HealthHealth-related Quality of Life+2 more
University of Manitoba35 enrolled1 locationNCT07628309
Recruiting

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

End Stage Renal DiseaseHemodialysis Access Failure
Merit Medical Systems, Inc.100 enrolled7 locationsNCT06422871
Recruiting

Changes in Regional Ventilation-Perfusion Match Following Percutaneous Transluminal Angioplasty for Arteriovenous Graft Thrombosis

End Stage Renal Disease on DialysisArteriovenous Graft Thrombosis
First Affiliated Hospital of Wannan Medical College20 enrolled1 locationNCT07613632
Recruiting

Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet

Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon20 enrolled7 locationsNCT07007338
Recruiting
Phase 1

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled3 locationsNCT06056102
Recruiting
Phase 4

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

End Stage Renal Disease on Dialysis
Yale University30 enrolled1 locationNCT05671991
Recruiting
Not Applicable

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

HemodialysisOxidative StressKidney Failure, Chronic
Universidade Federal Fluminense30 enrolled1 locationNCT06438445
Recruiting
Phase 3

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd.30 enrolled1 locationNCT07548840
Recruiting
Not Applicable

Exploring Water-free Sodium Storage

Peritoneal Dialysis, Heart Failure
Yale University10 enrolled1 locationNCT06872645
Recruiting
Not Applicable

AI-Guided Relaxation for Hemodialysis Anxiety

AnxietyMaintenance HemodialysisStress, Psychological+2 more
Alexandria University60 enrolled2 locationsNCT07522944
Recruiting
Not Applicable

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Quality of LifeFrailtyDialysis; Complications+1 more
Soonchunhyang University Hospital428 enrolled7 locationsNCT06141798
Recruiting
Not Applicable

Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients

haemodialysis patientsBlockage of Tunnelled Central Venous Access DevicePulsatile Flushing Technique
Queen Elizabeth Hospital, Hong Kong591 enrolled1 locationNCT07567456